Importantly, Zheng et al. identified DUB3 as a novel deubiquitinase that stabilizes VDR protein levels by interacting with its ligand-binding domain, thereby enhancing VDR’s protective effects and offering a promising therapeutic target for PD intervention. Here, VDR is linked to Parkinson disease.